Effect of Aerobic Training Versus Relaxation Techniques on Quality of Life in Patients With Post Covid-19 Irritable Bowel Syndrome
Key facts
- Who runs it
- Cairo University
- Where
- Egypt1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Not yet recruiting
- People taking part
- 60 people, planned
- Started
- 1 Feb 2025
- Planned end
- 15 May 2025
- Type of study
- Interventional, 3 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Aerobic training
- Relaxation techniques
- Low fodmap diet
- Record updated
- 28 January 2025
Who can take part
- Age
- 18 years to 30 years
- Sex
- Women only
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 18 criteriaShow less
Who can take part
- Body mass index range from 25 to 29.9 kg/m2
- Patients meeting the Rome IV diagnostic criteria for IBS, it is characterized by the presence of recurrent abdominal pain, on average, at least 1 day a week in the last 3 months with onset of symptoms at least 6 months before diagnosis, associated with 2 or more factors: related to defecation and/or associated with change in stool frequency and/or associated with change in stool form
- Clinically and medically stable
- Baseline IBS-SSS score from 75 to 299(mild and moderate)
- No medication for IBS (except for emergencies) within at least 2 weeks ago
- All patients are not following any type of diet protocol within 3 months prior to the treatment
Who cannot take part
- Using drugs that would affect metabolism
- Patient undergoes chemotherapy
- The patient has a history of rheumatic diseases in the lower limb
- Having a history of metabolic, neurologic, cardiovascular, respiratory, renal, and lung problems which would prevent them from participating in aerobic exercises
- Having a history of knee injury or knee surgery during the past year
- Having a history of fracture in the lower limb during the past six months
- Major vision disorders
- Hereditary or acquired musculoskeletal disorders in the lower limb
- Organic gastrointestinal disorders
- Intestinal organic diseases or systemic diseases affecting gastrointestinal motility (such as gallbladder pancreatitis, hyperthyroidism, diabetes, chronic renal insufficiency, and nervous system diseases)
- History of abdominal or rectal anus surgery
- Pregnancy or breastfeeding, and post-partum 12 months
Check if you might fit
Answer for yourself. This is not a decision: only the study team can say whether you can take part.
- Are you between 18 and 30 years old?
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The aim of this study is to compare the effect of aerobic training and relaxation techniques on quality of life in Post covid-19 patients with irritable bowel syndrome .
The 3 groups in the trial
- Aerobic training+ Low fodmap dietTreatment being tested
This group will include 20 patients. The participants will perform aerobic training (walking on treadmill 25-40 minutes 3 times per week) in addition they will follow a low fodmap diet three times/week for 6 weeks.
Treatment: Aerobic training and Low fodmap diet
- Relaxation techniques + Low fodmap dietTreatment being tested
This group will include 20 patients. The participants will perform the relaxation techniques in the form of mindfulness meditation and slow deep breathing in addition they will follow a low fodmap diet for 6 weeks
Treatment: Relaxation techniques and Low fodmap diet
- Low fodmap dietExisting treatment, for comparison
This group will include 20 patients. The participants will receive a low fodmap diet only for 6 weeks.
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Fit questions
- Built from NCT06795854, who can take part
- Record updated
- 28 January 2025